Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis

Sorafenib and lenvatinib, as molecular‐targeted agents, constitute effective primary treatment options for advanced hepatocellular carcinoma (HCC). However, the choice of optimal primary treatment agent remains controversial. Here, we aimed to assess the respective outcomes between these agents as p...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakano, Masahito, Kuromatsu, Ryoko, Niizeki, Takashi, Okamura, Shusuke, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Koga, Hironori, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395064/
https://www.ncbi.nlm.nih.gov/pubmed/32766480
http://dx.doi.org/10.1002/hep4.1535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395064/
https://www.ncbi.nlm.nih.gov/pubmed/32766480
http://dx.doi.org/10.1002/hep4.1535

Ejemplares similares